| Literature DB >> 26039976 |
Zejun Wei1, Yang Liu1, Heng Xu2, Kun Tang3, Hao Wu4, Lin Lu5, Zhe Wang6, Zhengjie Chen7, Junjie Xu8, Yufei Zhu1, Landian Hu1, Hong Shang8, Guoping Zhao9, Xiangyin Kong1.
Abstract
Genome-wide association studies (GWASs) have revealed several genetic loci associated with HIV-1 outcome following infection (e.g., HLA-C at 6p21.33) in multi-ethnic populations with genetic heterogeneity and racial/ethnic differences among Caucasians, African-Americans, and Hispanics. To systematically investigate the inherited predisposition to modulate HIV-1 infection in Chinese populations, we performed GWASs in three ethnically diverse HIV-infected patients groups (i.e., HAN, YUN, and XIN, N = 538). The reported loci at 6p21.33 was validated in HAN (e.g., rs9264942, P = 0.0018). An independent association signal (rs2442719, P = 7.85 × 10(-7), HAN group) in the same region was observed. Imputation results suggest that haplotype HLA-B*13:02/C*06:02, which can partially account for the GWAS signal, is associated with lower viral load in Han Chinese. Moreover, several novel loci were identified using GWAS approach including the top association signals at 6q13 (KCNQ5, rs947612, P = 2.15 × 10(-6)), 6p24.1 (PHACTR1, rs202072, P = 3.8 × 10(-6)), and 11q12.3 (SCGB1D4, rs11231017, P = 7.39 × 10(-7)) in HAN, YUN, and XIN groups, respectively. Our findings imply shared or specific mechanisms for host control of HIV-1 in ethnically diverse Chinese populations, which may shed new light on individualized HIV/AIDS therapy in China.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26039976 PMCID: PMC4454153 DOI: 10.1038/srep10879
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Phenotype and genotype characteristics of each cohort.
| Sample size | 288 | 154 | 96 |
| Ethnicity and sample sizes | Han 274/Other 14 | Han 52/Dai 58/Jingpo 40/Other 4 | Uygur 83/Hui 11/Other 2 |
| Mean age | 35.3 | 34.6 | 33.9 |
| Number of males/females | 250/38 | 146/8 | 94/2 |
| Mean viral load (and range) in log10 | 4.22 (2.38, 6.49) | 4.28 (2.54, 5.87) | 3.52 (1.30, 5.46) |
| Mean number of available viral-load points | 2.1 | 1.4 | 1.0 |
| Number of SNPs that passed quality control | 481,717 | 488,154 | 528,294 |
*In the HAN group, patients of other ethnicities (“other”) included Manchu, Dai, Korean, Zhuang and Hui ethnicities. In the YUN group, these others included A’chang, De’ang and Lisu ethnicities. In the XIN group, the others included Dongxiang and Ozbek ethnicities.
Figure 1Manhattan plot for host control of HIV-1 outcome following infection in the HAN group.
(A) Associations between genotype and HIV-1 viral-load set-point were evaluated using a linear regression model for 481,717 SNPs in the HAN group (N = 280). P values (-log10 P, y axis) were plotted against respective chromosomal position of each SNP (x-axis). Gene symbols are indicated for the top 2 loci, and the novel association SNP located gene KCNQ5 is highlighted in red. (B) and (C) Regional plots showing association results for SNPs spanning Chr6: 31.15-31.5 Mb at HLC-B and Chr6: 73.6-73.9 Mb at KCNQ5 locus, respectively in the HAN group. The plots were constructed using LocusZoom46: P values (-log10 P, y axis) were plotted against respective chromosomal positions of each SNP (x axis), and colors indicate LD (r2) with top signals in 1000 genomes from East Asian populations. The reported SNP rs9264942 (P = 0.0018) is highlighted within the red circle in Panel B.
Replication of significant SNPs reported in Caucasian and African American populations.
| rs2395029 | 6 | 31431780 | C/A | 1.61% | 0.1489 | 0.5229 | 0 | — | — | 6.11% | −0.0789 | 0.8112 | Caucasian | |
| rs9264942 | 6 | 31274380 | G/A | 48.21% | −0.1986 | 0.0018 | 44.30% | 0.04828 | 0.6291 | 39.44% | 0.1553 | 0.3233 | Caucasian | |
| rs2523608 | 6 | 31322559 | A/G | 42.14% | −0.0319 | 0.6018 | 35.23% | −0.0282 | 0.7881 | 39.44% | −0.2181 | 0.1437 | African American | |
| rs9262632 | 6 | 31024808 | G/A | 5.00% | −0.1625 | 0.2885 | 15.10% | 0.1649 | 0.2258 | 12.78% | 0.174 | 0.4287 | African American | |
| rs259919 | 6 | 30025503 | A/G | 23.93% | 0.1627 | 0.0201 | 23.15% | 0.1389 | 0.198 | 23.89% | −0.3281 | 0.0823 | Caucasian | |
| rs9468692 | 6 | 30119890 | A/C | 6.61% | 0.0016 | 0.9908 | 4.36% | −0.0735 | 0.7448 | 8.89% | 0.2324 | 0.3828 | Caucasian | |
| rs9266409 | 6 | 31336568 | G/A | 34.82% | 0.1516 | 0.0299 | 43.96% | −0.0588 | 0.5824 | 26.67% | 0.1049 | 0.5211 | Caucasian | |
| rs8192591 | 6 | 32185796 | A/G | 2.14% | −0.0206 | 0.9273 | 0 | — | — | 4.44% | 0.2773 | 0.4258 | Caucasian | |
“Chr” terms as chromosome; “MAF” terms as minor allele frequency.
#rs4418214, rs3131018 identified in a European population and rs2255221, rs2523590 identified in an African American population were not included in our chip.
*Significant SNPs in the HAN cohort.
Figure 2Viral-load distribution in patients with rs2442719, HLA-B*13:02 and HLA-C*06:02.
Viral loadings of patients with the AA allele at rs2442719 (A) and HLA-B*13:02/HLA-C*06:02 (B) were significantly lower than in other patients. The black lines denote the mean value and the error bar represents the standard error of the mean. Log10(viral load) (y axis) were plotted against patients with different alleles (x axis). P values were calculated using unpaired t test with Welch’s correction.
Association results of significant imputed HLA alleles.
| 9.30% | 2.58 × 10−5 | 1.34 × 10−2 | |
| 13.60% | 1.97 × 10−4 | 0.13 |
*P value of less than 2.50 × 10−4 is considered significant based on the Bonferroni correction.
Pcondition: P value of conditional test with rs2442719.
Association results of imputed amino acids (P < 0.05).
| 145 | L/R | α2 | 6.24 × 10−4 | 156 | L/W/R/D | α2 | 1.10 × 10−4 |
| 80 | N/I/T | α1 | 9.12 × 10−4 | 73 | A/T | α1 | 6.57 × 10−4 |
| −8 | V/L | Signal peptide | 1.85 × 10−3 | 116 | S/Y/L/F | α2 | 1.85 × 10−3 |
| 103 | L/V | α2 | 2.09 × 10−3 | 219 | W/R | α3 | 2.28 × 10−3 |
| 77 | S/N/D | α1 | 3.51 × 10−3 | 90 | D/A | α1 | 3.77 × 10−3 |
| 180 | E/Q | α2 | 5.05 × 10−3 | 304 | M/V | Transmembrane | 3.80 × 10−3 |
| 177 | D/E | α2 | 5.07 × 10−3 | 77 | N/S | α1 | 4.54 × 10−3 |
| 178 | K/T | α2 | 8.67 × 10−3 | 80 | K/N | α1 | 4.55 × 10−3 |
| 71 | A/T | α1 | 1.11 × 10−2 | 91 | R/G | α2 | 4.59 × 10−3 |
| 41 | T/A | α1 | 1.14 × 10−2 | 173 | K/E | α2 | 8.21 × 10−3 |
| 95 | L/W/I | α2 | 1.39 × 10−2 | 103 | V/L | α2 | 8.90 × 10−3 |
| −11 | S/W | Signal peptide | 1.61 × 10−2 | 95 | L/I/F | α2 | 9.00 × 10−3 |
| −16 | L/V | Signal peptide | 1.80 × 10−2 | 163 | T/L | α2 | 1.07 × 10−2 |
| 147 | H/Y | α2 | 1.80 × 10−2 | 94 | I/T | α2 | 1.24 × 10−2 |
| 143 | S/T | α2 | 1.81 × 10−2 | 1 | G/C | α1 | 1.31 × 10−2 |
| 82 | L/R | α1 | 2.01 × 10−2 | 9 | D/Y/S/F | α1 | 1.64 × 10−2 |
| 83 | R/G | α1 | 2.03 × 10−2 | 21 | H/R | α1 | 2.27 × 10−2 |
| 81 | A/L | α1 | 2.15 × 10−2 | 97 | W/R | α2 | 2.77 × 10−2 |
| 152 | E/V | α2 | 2.30 × 10−2 | ||||
| 74 | D/Y | α1 | 3.83 × 10−2 | ||||
| 305 | T/A | Transmembrane | 3.86 × 10−2 | ||||
| 282 | I/V | Connecting peptide | 4.03 × 10−2 | ||||
| 245 | T/A | α3 | 4.49 × 10−2 | ||||